Serum concentration of cystatin C is not affected by cellular proliferation in patients with proliferative haematological disorders

Annals of Clinical Biochemistry

Volumn 39, Issue 3, 2002, Pages 308-310

  Mojiminiyi, Olusegun A ^a   Marouf, R ^a   Abdella, N ^a   Kortom, M ^a   Abdul Razzak, R ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CREATININE; CYSTATIN C;

ACUTE LEUKEMIA; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD DISEASE; CELL PROLIFERATION; CHRONIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; KIDNEY FUNCTION; LYMPHOMA; MALE; MULTIPLE MYELOMA; MYELOFIBROSIS; POLYCYTHEMIA VERA; PRIORITY JOURNAL; THROMBOCYTHEMIA;

CELL DIVISION; CREATININE; CYSTATINS; FEMALE; GLOMERULAR FILTRATION RATE; HEMATOLOGIC DISEASES; HUMANS; MALE;

EID: 0036257576     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563021902017     Document Type: Article

References (6)

1. Beta 2-microglobulin and the kidney: An overview
2. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients
3. Prediction of creatinine clearance from serum creatinine
4. Reference intervals for the glomerular filtration rate and cell-proliferation markers: Serum cystatin C and serum beta2-microglobulin/cystatin C-ratio
5. Developments in the assessment of glomerular filtration rate
6. Serum cystatin C in patients with myeloma